164 related articles for article (PubMed ID: 8152238)
1. Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography.
Miyazawa H; Osmont A; Petit-Taboué MC; Tillet I; Travère JM; Young AR; Barré L; MacKenzie ET; Baron JC
J Neurosci Methods; 1993 Dec; 50(3):263-72. PubMed ID: 8152238
[TBL] [Abstract][Full Text] [Related]
2. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
3. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
Kuwabara H; Gjedde A
J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
[TBL] [Abstract][Full Text] [Related]
4. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
[TBL] [Abstract][Full Text] [Related]
5. In vivo measurement of [18F]fluorodeoxyglucose rate constants in rat brain by external coincidence counting.
Redies C; Matsuda H; Diksic M; Meyer E; Yamamoto YL
Neuroscience; 1987 Aug; 22(2):593-9. PubMed ID: 3670599
[TBL] [Abstract][Full Text] [Related]
6. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A
J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
[TBL] [Abstract][Full Text] [Related]
7. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
Kuwabara H; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
[TBL] [Abstract][Full Text] [Related]
8. Analysis of kinetic rate constants in [18F]fluorodeoxyglucose model using a least square fitting package SALS (statistical analysis with least squares).
Uehara S; Kuwabara Y; Ichiya Y; Otsuka M; Ayabe Y; Miyake Y; Masuda K; Yoshimura A
Radioisotopes; 1987 Dec; 36(12):653-6. PubMed ID: 3502293
[TBL] [Abstract][Full Text] [Related]
9. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
Dhawan V; Moeller JR; Strother SC; Evans AC; Rottenberg DA
J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
[TBL] [Abstract][Full Text] [Related]
10. [Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
Enomoto K; Fukunaga T; Okazumi S; Asano T; Kikuchi T; Yamamoto H; Nagashima T; Isono K; Itoh H; Imazeki K
Kaku Igaku; 1991 Nov; 28(11):1353-6. PubMed ID: 1663176
[TBL] [Abstract][Full Text] [Related]
11. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
12. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver.
Choi Y; Hawkins RA; Huang SC; Brunken RC; Hoh CK; Messa C; Nitzsche EU; Phelps ME; Schelbert HR
J Nucl Med; 1994 May; 35(5):818-23. PubMed ID: 8176464
[TBL] [Abstract][Full Text] [Related]
14. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Herholz K; Rudolf J; Heiss WD
J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
[TBL] [Abstract][Full Text] [Related]
15. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.
Sugawara Y; Zasadny KR; Grossman HB; Francis IR; Clarke MF; Wahl RL
Radiology; 1999 Apr; 211(1):249-56. PubMed ID: 10189480
[TBL] [Abstract][Full Text] [Related]
16. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
Okazumi S; Isono K; Enomoto K; Kikuchi T; Ozaki M; Yamamoto H; Hayashi H; Asano T; Ryu M
J Nucl Med; 1992 Mar; 33(3):333-9. PubMed ID: 1311035
[TBL] [Abstract][Full Text] [Related]
18. A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue.
Wu HM; Huang SC; Choi Y; Hoh CK; Hawkins RA
J Nucl Med; 1995 Feb; 36(2):297-306. PubMed ID: 7830134
[TBL] [Abstract][Full Text] [Related]
19. Short dynamic FDG-PET imaging protocol for patients with lung cancer.
Torizuka T; Nobezawa S; Momiki S; Kasamatsu N; Kanno T; Yoshikawa E; Futatsubashi M; Okada H; Ouchi Y
Eur J Nucl Med; 2000 Oct; 27(10):1538-42. PubMed ID: 11083544
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
Spence AM; Muzi M; Mankoff DA; O'Sullivan SF; Link JM; Lewellen TK; Lewellen B; Pham P; Minoshima S; Swanson K; Krohn KA
J Nucl Med; 2004 Oct; 45(10):1653-9. PubMed ID: 15471829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
